FDG-PET/CT Assessment of Pulmonary Sarcoidosis: A Guide for Internists

Curr Med Imaging Rev. 2019;15(1):21-25. doi: 10.2174/1573405614666180528101755.

Abstract

Background: 18F-fluorodeoxyglucose positron emission tomography integrated with computed tomography (18-F-FDG-PET/CT) is getting wide consensus in the diagnosis and staging of neoplastic disorders and represents a useful tool in the assessment of various inflammatory conditions.

Discussion: Sarcoidosis is an uncommon disease characterized by the systemic formation of noncaseating granulomas. Lungs are the sites most often affected, and investigation with high resolution computed tomography and biopsy is essential to achieve a correct diagnosis. 18-F-FDGPET/ CT is effective in the assessment of pulmonary sarcoidosis by demonstrating pulmonary and extrathoracic involvement and findings correlate well with pulmonary function in patients affected.

Conclusion: This review would illustrate the usefulness and limits of 18-F-FDG-PET/CT in the assessment of pulmonary sarcoidosis.

Keywords: (HIV)-related infections; CT; FDG-PET; Internist; musculoskeletal infections; pulmonary sarcoidosis.

Publication types

  • Review

MeSH terms

  • Fluorodeoxyglucose F18 / metabolism
  • Humans
  • Positron Emission Tomography Computed Tomography / methods*
  • Sarcoidosis, Pulmonary / diagnostic imaging*

Substances

  • Fluorodeoxyglucose F18